Fertility and Sterility
Volume 79, Issue 2 , Pages 268-273 , February 2003

Effect of tibolone treatment on intima-media thickness and the resistive indices of the carotid arteries

  • Mithat Erenus, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Marmara University School of Medicine, Istanbul, Turkey
    • Corresponding Author InformationReprint requests: Mithat Erenus, M.D., Gulistan sk. 13/6, 81060 Goztepe, Istanbul, Turkey (FAX: 90-216-326-68-09).
    • ,
  • A.Hakan Ilhan, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Marmara University School of Medicine, Istanbul, Turkey
    • ,
  • Koray Elter, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Marmara University School of Medicine, Istanbul, Turkey

Received 14 February 2002 ,Revised 5 June 2002 ,Accepted 5 June 2002.

References 

  1. Seed M. Postmenopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins. Drugs. 1994;47(Suppl 2):25–34
  2. Zandberg P, Peters JLM, Demacker PN, de Reeder EG, Smit MJ, Meuleman DG. Comparison of the antiatherosclerotic effect of tibolone with that of estradiol and ethinyl estradiol in cholesterol-fed, ovariectomized rabbits. Menopause. 2001;8:96–105
  3. Barrett-Connor E. The menopause, hormone replacement, and cardiovascular disease (the epidemiologic evidence). Maturitas. 1996;23:227–234
  4. Kafonek SD. Postmenopausal hormone replacement therapy and cardiovascular risk reduction. Drugs. 1994;47(Suppl 2):16–24
  5. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA. 1991;265:1861–1867
  6. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, et al.  Cardiovascular mortality and noncontraceptive use of estrogen in women (results from the Lipid Research Clinics Program Follow-up Study). Circulation. 1987;75:1102–1109
  7. Mendelsohn ME, Karas RH. Estrogen and the blood vessel wall. Curr Opin Cardiol. 1994;9:619–626
  8. Vidovic IP, Demarin V, Grubisic G, Kuna K, Huzjan AL. Carotid artery intima thickness and flow velocity after discontinuation of hormone replacement therapy in postmenopausal women (follow-up study). Croat Med J. 2001;42:54–57
  9. Tremollieres FA, Cigagna F, Alquier C, Cauneille C, Pouilles J, Ribot C. Effects of hormone replacement therapy on age-related increase in carotid artery intima-media thickness in postmenopausal women. Atherosclerosis. 2000;153:81–88
  10. Westendorp IC, in ’t Veld BA, Bots ML, Akkerhuis JM, Hofman A, Grobbee DE, et al.  Hormone replacement therapy and intima-media thickness of the common carotid artery (the Rotterdam study). Stroke. 1999;30:2562–2567
  11. Signorelli SS, Salvatore S, Luigi D, Pia CM, Giuseppe P, Sarina C. Serum lipids and lipoproteins and carotid artery wall intima-media thickness in a population of menopausal women. Menopause. 1999;6:230–232
  12. Griewing B, Romer T, Spitzer C, Ludemann J, Gunther A, Kessler C. Hormone replacement therapy in postmenopausal women (carotid intima-media thickness and 3-D volumetric plaque quantification). Maturitas. 1999;32:33–40
  13. Anderson HV. Estrogen therapy, atherosclerosis, and clinical cardiovascular events. Circulation. 1996;94:1809–1811
  14. Muscat Baron Y, Brincat M, Galea R. Carotid artery wall thickness in women treated with hormone replacement therapy. Maturitas. 1997;27:47–53
  15. Moore RA. Livial (a review of clinical studies). Br J Obstet Gynaecol. 1999;106(Suppl 19):1–21
  16. O’Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK, et al.  Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke. 1992;23:1752–1760
  17. Allan PL, Mowbray PI, Lee AJ, Fowkes FG. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease. The Edinburgh Artery Study. Stroke. 1997;28:348–353
  18. Blankenhorn DH, Rooney JA, Curry PJ. Noninvasive assessment of atherosclerosis. Prog Cardiovasc Dis. 1984;26:295–307
  19. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall (a direct measurement with ultrasound imaging). Circulation. 1986;74:1399–1406
  20. Howard G, Sharrett AR, Heiss G, Evans GW, Chambless LE, Riley WA, et al.  Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke. 1993;24:1297–1304
  21. Salonen R, Salonen JT. Determinants of carotid intima-media thickness (a population-based ultrasonography study in Eastern Finnish men). J Intern Med. 1991;229:225–231
  22. Poli A, Tremoli E, Colombo A, Sirtori M, Pignoli P, Paoletti R. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients (a new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects). Atherosclerosis. 1988;70:253–261
  23. Mannami T, Konishi M, Baba S, Nishi N, Terao A. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city (the Suita study). Stroke. 1997;28:518–525
  24. Bots ML, Breslau PJ, Briet E, de Bruyn AM, van Vliet HH, van den Ouweland FA, et al.  Cardiovascular determinants of carotid artery disease (the Rotterdam Elderly Study). Hypertension. 1992;19:717–720
  25. Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW, et al.  Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 1995;26:386–391
  26. Frauchiger B, Schmid HP, Roedel C, Moosmann P, Staub D. Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis. Stroke. 2001;32:836–841
  27. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605–613
  28. Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, et al.  Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med. 2000;343:522–529
  29. Jonas HA, Kronmal RA, Psaty BM, Manolio TA, Meilahn EN, Tell GS, et al.  Current estrogen-progestin and estrogen replacement therapy in elderly women (association with carotid atherosclerosis. CHS Collaborative Research Group. Cardiovascular Health Study). Ann Epidemiol. 1996;6:314–323
  30. McGrath BP, Liang YL, Teede H, Shiel LM, Cameron JD, Dart A. Age-related deterioration in arterial structure and function in postmenopausal women (impact of hormone replacement therapy). Arterioscler Thromb Vasc Biol. 1998;18:1149–1156
  31. Punnonen R, Jokela H, Heinonen PK, Aine R, Dastidar P. Hormone replacement therapy and atherosclerosis. J Reprod Med. 1995;40:267–272
  32. Espeland MA, Applegate W, Furberg CD, Lefkowitz D, Rice L, Hunninghake D. Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study. Am J Epidemiol. 1995;142:1011–1019
  33. Albertazzi P, Di Micco R, Zanardi E. Tibolone (a review). Maturitas. 1998;30:295–305
  34. Rymer JM. The effects of tibolone. Gynecol Endocrinol. 1998;12:213–220
  35. Hardiman P, Nihoyannopoulos P, Kicovic P, Ginsburg J. Cardiovascular effects of Org OD 14—a new steroidal therapy for climacteric symptoms. Maturitas. 1991;13:235–242
  36. Lloyd GW, Patel NR, McGing EA, Cooper AF, Kamalvand K, Jackson G. Acute effects of hormone replacement with tibolone on myocardial ischaemia in women with angina. Int J Clin Pract. 1998;52:155–157
  37. Lehmann ED, Hopkins KD, Parker JR, Turay RC, Rymer J, Fogelman I, et al.  Aortic distensibility in post-menopausal women receiving Tibolone. Br J Radiol. 1994;67:701–705
  38. Clarkson TB, Anthony MS, Wagner JD. A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys. J Clin Endocrinol Metab. 2001;86:5396–5404
  39. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340:14–22
  40. Espeland MA, Applegate W, Furberg CD, Lefkowitz D, Rice L, Hunninghake D. Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study. Am J Epidemiol. 1995;142:1011–1019
  41. Muscat Baron Y, Galea R, Brincat M. Carotid artery wall changes in estrogen-treated and -untreated postmenopausal women. Obstet Gynecol. 1998;91:982–986
  42. Nabulsi AA, Folsom AR, Szklo M, White A, Higgins M, Heiss G. No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Circulation. 1996;94:1857–1863
  43. Hashimoto M, Miyao M, Akishita M, Hosoi T, Toba K, Kozaki K, et al.  Effects of long-term and reduced-dose hormone replacement therapy on endothelial function and intima-media thickness in postmenopausal women. Menopause. 2002;9:58–64
  44. Pontremoli R, Viazzi F, Martinoli C, Ravera M, Nicolella C, Berruti V, et al.  Increased renal resistive index in patients with essential hypertension (a marker of target organ damage). Nephrol Dial Transp. 1999;14:360–365
  45. Ishimura E, Nishizawa Y, Kawagishi T, Okuno Y, Kogawa K, Fukumoto S, et al.  Intrarenal hemodynamic abnormalities in diabetic nephropathy measured by duplex Doppler sonography. Kidney Int. 1997;51:1920–1927
  46. Frauchiger B, Nussbaumer P, Hugentobler M, Staub D. Duplex sonographic registration of age and diabetes-related loss of renal vasodilatory response to nitroglycerine. Nephrol Dial Transplant. 2000;15:827–832
  47. Ginsburg J, Prelevic GM. Tibolone and the serum lipid/lipoprotein profile (does this have a role in cardiovascular protection in postmenopausal women?). Menopause. 1999;6:87–89

☆ Supported by Organon A.S., Istanbul, Turkey.

PII: S0015-0282(02)04580-6

doi: 10.1016/S0015-0282(02)04580-6

Fertility and Sterility
Volume 79, Issue 2 , Pages 268-273 , February 2003

Article Tools

* Image Usage & Resolution